Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1994-12-02
1996-09-03
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4241861, 4242307, 4242331, 4242781, 435 691, 435 693, 4351723, 4352351, 536 231, 536 2372, A61K 39295, A61K 39245, A61K 39235
Patent
active
055521436
ABSTRACT:
The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit, an immunogenic fragment of the gB subunit, and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being useful as a vaccine.
REFERENCES:
patent: 3959466 (1976-05-01), Plotkin
patent: 4920209 (1990-04-01), Davis et al.
patent: 5124440 (1992-06-01), Gehrz et al.
Lerner et al, The Biology of Immunologic Disease, Sinauer Assoc., Inc., The Development of Synthetic Vaccines, 1983.
S. A. Plotkin et al, "Prevention of Cytomegalovirus Disease by Towne Strain Live Attenuated Vaccine", in Birth Defects, Original Article Series, 20(1):271-287 (1984).
J. P. Glazer et al, Ann. Intern. Med., 91:676-683 (1979).
J. Hanshaw, J. Infect. Dis., 123(5):555 (1971).
S. A. Plotkin et al, Lancet, 1:528-530 (1984).
S. A. Plotkin et al, J. Infect. Dis., 134(5):470-475 (1976).
M. P. Cranage et al, Embo J., 5:3057-3063 (1986).
D. C. Johnson et al, Virol., 164:1-14 (1988).
R. L. Dewar et al, J. Virol., 63(1):129-136 (1988).
A. R. Davis et al, Proc. Natl. Acad. Sci. USA, 82:7560-7564 (1985).
J. E. Morin et al, Proc. Natl. Acad. Sci. USA, 84:4626-4630 (1987).
R. B. Couch et al, Am. Rev. Respir. Dis., 88:394-403 (1963).
E. T. Takafuji et al, J. Infect. Dis., 140(1):48-53 (1979).
P. B. Collis et al, J. Infect. Dis., 128(6):745-752 (1973).
Berencsi Klara
Gonczol Ewa
Plotkin Stanley A.
Rando Robert F.
Ricciardi Robert P.
Mosher Mary E.
Scheiner Laurie
The United States of America as represented by the Department of
The Wistar Institute of Anatomy & Biology
LandOfFree
Recombinant cytomegalovirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant cytomegalovirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant cytomegalovirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948387